As life sciences companies look for ways to improve diversity, equity and inclusion both within their organisations and in healthcare as a whole, PM360 turned to 10 experts in the space to ask them how. In this article, Joshua Bueller, Account VP and Senior Strategy Consultant at ICON, describes how pharma companies can gain a better understanding into the needs of underrepresented and underserved groups using a patient-centric, data-driven approach.